Walleye Trading
DMAQR

Walleye Trading’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Walleye Trading’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-151,758
Closed -$45.5K – 5626
2023
Q4 		$45.5K Hold
151,758
– – ﹤0.01% 4361
2023
Q3 		$53K Hold
151,758
– – ﹤0.01% 4192
2023
Q2 		$24.3K Buy
151,758
+56,322
+59% +$9.21K ﹤0.01% 4098
2023
Q1 		$13.8K Buy
95,436
+16,200
+20% +$1.64K ﹤0.01% 4309
2022
Q4 		$4.75K Hold
79,236
– – ﹤0.01% 4602
2022
Q3 		$3K Hold
79,236
– – ﹤0.01% 4755
2022
Q2 		$9K Buy
79,236
+36
+0% +$6 ﹤0.01% 4670
2022
Q1 		$14K Hold
79,200
– – ﹤0.01% 4852
2021
Q4 		$25K Buy
+79,200
New +$25.1K ﹤0.01% 4867

Walleye Trading's DMAQR Position: Q1 2024 in Review

Walleye Trading sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 151,758 shares — an estimated $45.5K sold.

Walleye Trading first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $53K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • Walleye Trading reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 151,758 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $45.5K.
  • Walleye Trading first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
  • Walleye Trading's Deep Medicine Acquisition Corp. Rights position peaked at $53K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.